Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?
作者信息
Mizusawa Masako, Miller Heather, Green Rachel, Lee Richard, Durante Mariann, Perkins Rosalie, Hewitt Caroline, Simner Patricia J, Carroll Karen C, Hayden Randall T, Zhang Sean X
机构信息
Division of Medical Microbiology, Department of Pathology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA.
Microbiology Laboratory, Johns Hopkins Hospital, Johns Hopkins Medical Institutions, Baltimore, Maryland, USA.
出版信息
J Clin Microbiol. 2017 Feb;55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23.
Abstract
摘要
相似文献
1
Can Multidrug-Resistant Candida auris Be Reliably Identified in Clinical Microbiology Laboratories?
J Clin Microbiol. 2017 Feb;55(2):638-640. doi: 10.1128/JCM.02202-16. Epub 2016 Nov 23.
2
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
J Clin Microbiol. 2015 Jun;53(6):1823-30. doi: 10.1128/JCM.00367-15. Epub 2015 Mar 25.
3
Candida auris Clinical Isolates from South Korea: Identification, Antifungal Susceptibility, and Genotyping.
J Clin Microbiol. 2019 Mar 28;57(4). doi: 10.1128/JCM.01624-18. Print 2019 Apr.
4
Usefulness of MALDI-TOF Mass Spectrometry for Routine Identification of Candida Species in a Resource-Poor Setting.
Mycopathologia. 2015 Oct;180(3-4):173-9. doi: 10.1007/s11046-015-9905-2. Epub 2015 May 28.
5
Evaluation of two matrix-assisted laser desorption ionization-time of flight mass spectrometry (MALDI-TOF MS) systems for the identification of Candida species.
Clin Microbiol Infect. 2014 Feb;20(2):153-8. doi: 10.1111/1469-0691.12210. Epub 2013 Apr 17.
6
Identification and typing of the emerging pathogen Candida auris by matrix-assisted laser desorption ionisation time of flight mass spectrometry.
Mycoses. 2016 Aug;59(8):535-8. doi: 10.1111/myc.12519. Epub 2016 Jun 13.
7
Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris.
J Clin Microbiol. 2017 Dec;55(12):3324-3327. doi: 10.1128/JCM.01355-17. Epub 2017 Sep 13.
8
Usefulness of CHROMagar Candida Medium, Biochemical Methods--API ID32C and VITEK 2 Compact and Two MALDI-TOF MS Systems for Candida spp. Identification.
Pol J Microbiol. 2016;65(1):111-4. doi: 10.5604/17331331.1197283.
9
Comparison of Vitek Matrix-assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry Versus Conventional Methods in Candida Identification.
Mycopathologia. 2016 Feb;181(1-2):67-73. doi: 10.1007/s11046-015-9944-8. Epub 2015 Sep 23.
10
Simple low cost differentiation of Candida auris from Candida haemulonii complex using CHROMagar Candida medium supplemented with Pal's medium.
Rev Iberoam Micol. 2017 Apr-Jun;34(2):109-111. doi: 10.1016/j.riam.2016.11.004. Epub 2017 Apr 6.
引用本文的文献
1
Expansion of the Candidozyma haemuli Species Complex - The Novel Species Candidozyma molenica, Isolated from Clinical and Environmental Sources.
Mycopathologia. 2025 Sep 1;190(5):81. doi: 10.1007/s11046-025-00985-z.
2
Diagnostic Approaches for : A Comprehensive Review of Screening, Identification, and Susceptibility Testing.
Microorganisms. 2025 Jun 24;13(7):1461. doi: 10.3390/microorganisms13071461.
3
Evaluation of a high-throughput assay for use on the cobas 5800/6800/8800 omni Utility Channel.
Microbiol Spectr. 2025 Jul;13(7):e0025425. doi: 10.1128/spectrum.00254-25. Epub 2025 May 16.
4
Is routine screening for necessary in ICU?
Iran J Microbiol. 2024 Oct;16(5):708-715. doi: 10.18502/ijm.v16i5.16807.
5
Application of Raman spectroscopy and machine learning for identification and characterization.
Appl Environ Microbiol. 2024 Nov 20;90(11):e0102524. doi: 10.1128/aem.01025-24. Epub 2024 Oct 29.
6
Assessment of LAMPAuris for Rapid Detection of Candida auris in Clinical Specimens.
Mycopathologia. 2024 Sep 23;189(5):87. doi: 10.1007/s11046-024-00892-9.
7
The laboratory investigation, management, and infection prevention and control of : a narrative review to inform the 2024 national guidance update in England.
J Med Microbiol. 2024 May;73(5). doi: 10.1099/jmm.0.001820.
8
Validation of a qualitative real-time PCR assay for the detection of in hospital inpatient screening.
J Clin Microbiol. 2024 Jun 12;62(6):e0015824. doi: 10.1128/jcm.00158-24. Epub 2024 May 1.
9
Outbreak in a Multidisciplinary Hospital in Romania during the Post-Pandemic Era: Potential Solutions and Challenges in Surveillance and Epidemiological Control.
Antibiotics (Basel). 2024 Apr 3;13(4):325. doi: 10.3390/antibiotics13040325.
10
Identification and antifungal susceptibility testing of Candida haemulonii complex isolated from clinical samples.
Folia Microbiol (Praha). 2024 Feb;69(1):165-171. doi: 10.1007/s12223-023-01122-3. Epub 2023 Dec 26.
本文引用的文献
1
Comparative Pathogenicity of United Kingdom Isolates of the Emerging Pathogen Candida auris and Other Key Pathogenic Candida Species.
mSphere. 2016 Aug 18;1(4). doi: 10.1128/mSphere.00189-16. eCollection 2016 Jul-Aug.
2
Rapid identification of 6328 isolates of pathogenic yeasts using MALDI-ToF MS and a simplified, rapid extraction procedure that is compatible with the Bruker Biotyper platform and database.
Med Mycol. 2016 Jan;54(1):80-8. doi: 10.1093/mmy/myv085. Epub 2015 Nov 21.
3
Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
J Clin Microbiol. 2015 Jun;53(6):1823-30. doi: 10.1128/JCM.00367-15. Epub 2015 Mar 25.
4
New clonal strain of Candida auris, Delhi, India.
Emerg Infect Dis. 2013 Oct;19(10):1670-3. doi: 10.3201/eid1910.130393.
Zotero 插件